Search research articles
Contact Us
Filters
Showing results (381-390 of 473) with videos related to
Page
of 48
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 29, 2007
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
Manuel Jurado, Carlos Vallejo, José A Pérez-Simón, et al.
Medicina Clinica
|
May 10, 1981
[Primary double neoplasias (author's transl)]
J M Ribera Casado, A Ruiz de Aguiar González, R Pieltain Alvarez-Arenas, et al.
The British Journal of Dermatology
|
November 20, 2018
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
M Potrony, J A Puig-Butille, M Ribera-Sola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 1998
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
A López-Guillermo, J Cid, A Salar, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 15, 2018
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study
G Deza, J Notario, A Lopez-Ferrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)
Dolores Caballero, Jose A García-Marco, Rodrigo Martino, et al.
Oncology and Therapy
|
July 24, 2020
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2008
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
S Mercadal, J Briones, B Xicoy, et al.
Bone Marrow Transplantation
|
April 30, 2014
The commitment and evaluation of the quality management plan by professionals from accredited stem cell transplant centers in Spain
M-J Jiménez, C Ferra, O García, et al.
Leukemia
|
December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy
A Pérez-García, S Brunet, J J Berlanga, et al.
Page
of 48
Search research articles
Search
Showing results (381-390 of 473) with videos related to
Sort By:
Page
of 48
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 29, 2007
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
Manuel Jurado, Carlos Vallejo, José A Pérez-Simón, et al.
Medicina Clinica
|
May 10, 1981
[Primary double neoplasias (author's transl)]
J M Ribera Casado, A Ruiz de Aguiar González, R Pieltain Alvarez-Arenas, et al.
The British Journal of Dermatology
|
November 20, 2018
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
M Potrony, J A Puig-Butille, M Ribera-Sola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 1998
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
A López-Guillermo, J Cid, A Salar, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 15, 2018
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study
G Deza, J Notario, A Lopez-Ferrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)
Dolores Caballero, Jose A García-Marco, Rodrigo Martino, et al.
Oncology and Therapy
|
July 24, 2020
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2008
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
S Mercadal, J Briones, B Xicoy, et al.
Bone Marrow Transplantation
|
April 30, 2014
The commitment and evaluation of the quality management plan by professionals from accredited stem cell transplant centers in Spain
M-J Jiménez, C Ferra, O García, et al.
Leukemia
|
December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy
A Pérez-García, S Brunet, J J Berlanga, et al.
Page
of 48